Repligen | RGEN - 流动资产

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 7.28B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	流动资产	更改		日
Agilent	USD 4.76B		148M	2026-03
Align Technology	USD 2.66B		38.87M	2026-03
Bio Techne	USD 688.05M		50.62M	2026-03
BioMarin Pharmaceutical	USD 4.61B		651.58M	2026-03
Bristol-Myers Squibb	USD 27.21B		2.18B	2026-03
Bruker	USD 2.1B		108.9M	2026-03
Charles River Laboratories	USD 1.49B		41.76M	2026-03
Danaher	USD 13.94B		1.18B	2026-03
Dentsply International	USD 1.85B		178M	2026-03
General Electric Aerospace	USD 40.36B		235M	2026-03
Henry Schein	USD 4.5B		32M	2026-03
Illumina	USD 2.74B		551M	2026-03
IQVIA Holdings	USD 6.22B		29M	2026-03
Mettler Toledo International	USD 1.33B		30.76M	2026-03
Myriad Genetics	USD 312.8M		19.8M	2026-03
OraSure Technologies	USD 240.78M		21.13M	2026-03
Pacific Biosciences Of California	USD 369.52M		5.54M	2026-03
Pfizer	USD 42.82B		76M	2026-03
Repligen	USD 1.16B		23.98M	2026-03
Revvity	USD 2.13B		111.43M	2026-03
Standard Biotools	USD 521.45M		67.19M	2026-03
Thermo Fisher Scientific	USD 22.32B		6.39B	2026-03
Waters	USD 3.72B		1.73B	2026-03
West Pharmaceutical Services	USD 1.83B		151.4M	2026-03